August 5, 2012 · STOCK Act disclosure
Representative James B. Renacci (Republican-OH) bought Alexion Pharmaceuticals, Inc., a stock transaction, valued at $2,129.25. The trade took place on August 5, 2012 and was disclosed on May 15, 2013 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.